世界の辺縁帯リンパ腫治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Marginal Zone Lymphoma Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4461 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、辺縁帯リンパ腫治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、放射線療法、免疫療法、その他）、用途別市場規模（病院、クリニック、外来手術センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・辺縁帯リンパ腫治療の市場動向 ・企業の競争状況、市場シェア ・辺縁帯リンパ腫治療の種類別市場規模と予測2016-2027（化学療法、放射線療法、免疫療法、その他） ・辺縁帯リンパ腫治療の用途別市場規模と予測2016-2027（病院、クリニック、外来手術センター、その他） ・辺縁帯リンパ腫治療の北米市場規模2016-2027（アメリカ、カナダ） ・辺縁帯リンパ腫治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・辺縁帯リンパ腫治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・辺縁帯リンパ腫治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・辺縁帯リンパ腫治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Incyte Corporation、Bristol-Myers Squibb、Astellas Pharma、TG Therapeutics、Genmab AS、Roche、GSK、Johnson & Johnson、Novartis、Merck） ・結論

Market Analysis and Insights: Global Marginal Zone Lymphoma Treatment Market
The global Marginal Zone Lymphoma Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Marginal Zone Lymphoma Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Marginal Zone Lymphoma Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Marginal Zone Lymphoma Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Marginal Zone Lymphoma Treatment market.

Global Marginal Zone Lymphoma Treatment Scope and Market Size
Marginal Zone Lymphoma Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Marginal Zone Lymphoma Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Radiation Therapy
Immunotherapy
Others

Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Incyte Corporation
Bristol-Myers Squibb
Astellas Pharma
TG Therapeutics
Genmab AS
Roche
GSK
Johnson & Johnson
Novartis
Merck

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Marginal Zone Lymphoma Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Immunotherapy
1.2.5 Others
1.3 Market by Application
1.3.1 Global Marginal Zone Lymphoma Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Marginal Zone Lymphoma Treatment Market Perspective (2016-2027)
2.2 Marginal Zone Lymphoma Treatment Growth Trends by Regions
2.2.1 Marginal Zone Lymphoma Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Marginal Zone Lymphoma Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Marginal Zone Lymphoma Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Marginal Zone Lymphoma Treatment Industry Dynamic
2.3.1 Marginal Zone Lymphoma Treatment Market Trends
2.3.2 Marginal Zone Lymphoma Treatment Market Drivers
2.3.3 Marginal Zone Lymphoma Treatment Market Challenges
2.3.4 Marginal Zone Lymphoma Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Marginal Zone Lymphoma Treatment Players by Revenue
3.1.1 Global Top Marginal Zone Lymphoma Treatment Players by Revenue (2016-2021)
3.1.2 Global Marginal Zone Lymphoma Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Marginal Zone Lymphoma Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Marginal Zone Lymphoma Treatment Revenue
3.4 Global Marginal Zone Lymphoma Treatment Market Concentration Ratio
3.4.1 Global Marginal Zone Lymphoma Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Marginal Zone Lymphoma Treatment Revenue in 2020
3.5 Marginal Zone Lymphoma Treatment Key Players Head office and Area Served
3.6 Key Players Marginal Zone Lymphoma Treatment Product Solution and Service
3.7 Date of Enter into Marginal Zone Lymphoma Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Marginal Zone Lymphoma Treatment Breakdown Data by Type
4.1 Global Marginal Zone Lymphoma Treatment Historic Market Size by Type (2016-2021)
4.2 Global Marginal Zone Lymphoma Treatment Forecasted Market Size by Type (2022-2027)

5 Marginal Zone Lymphoma Treatment Breakdown Data by Application
5.1 Global Marginal Zone Lymphoma Treatment Historic Market Size by Application (2016-2021)
5.2 Global Marginal Zone Lymphoma Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Marginal Zone Lymphoma Treatment Market Size (2016-2027)
6.2 North America Marginal Zone Lymphoma Treatment Market Size by Type
6.2.1 North America Marginal Zone Lymphoma Treatment Market Size by Type (2016-2021)
6.2.2 North America Marginal Zone Lymphoma Treatment Market Size by Type (2022-2027)
6.2.3 North America Marginal Zone Lymphoma Treatment Market Size by Type (2016-2027)
6.3 North America Marginal Zone Lymphoma Treatment Market Size by Application
6.3.1 North America Marginal Zone Lymphoma Treatment Market Size by Application (2016-2021)
6.3.2 North America Marginal Zone Lymphoma Treatment Market Size by Application (2022-2027)
6.3.3 North America Marginal Zone Lymphoma Treatment Market Size by Application (2016-2027)
6.4 North America Marginal Zone Lymphoma Treatment Market Size by Country
6.4.1 North America Marginal Zone Lymphoma Treatment Market Size by Country (2016-2021)
6.4.2 North America Marginal Zone Lymphoma Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Marginal Zone Lymphoma Treatment Market Size (2016-2027)
7.2 Europe Marginal Zone Lymphoma Treatment Market Size by Type
7.2.1 Europe Marginal Zone Lymphoma Treatment Market Size by Type (2016-2021)
7.2.2 Europe Marginal Zone Lymphoma Treatment Market Size by Type (2022-2027)
7.2.3 Europe Marginal Zone Lymphoma Treatment Market Size by Type (2016-2027)
7.3 Europe Marginal Zone Lymphoma Treatment Market Size by Application
7.3.1 Europe Marginal Zone Lymphoma Treatment Market Size by Application (2016-2021)
7.3.2 Europe Marginal Zone Lymphoma Treatment Market Size by Application (2022-2027)
7.3.3 Europe Marginal Zone Lymphoma Treatment Market Size by Application (2016-2027)
7.4 Europe Marginal Zone Lymphoma Treatment Market Size by Country
7.4.1 Europe Marginal Zone Lymphoma Treatment Market Size by Country (2016-2021)
7.4.2 Europe Marginal Zone Lymphoma Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size (2016-2027)
8.2 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Type
8.2.1 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Application
8.3.1 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Region
8.4.1 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Marginal Zone Lymphoma Treatment Market Size (2016-2027)
9.2 Latin America Marginal Zone Lymphoma Treatment Market Size by Type
9.2.1 Latin America Marginal Zone Lymphoma Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Marginal Zone Lymphoma Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Marginal Zone Lymphoma Treatment Market Size by Type (2016-2027)
9.3 Latin America Marginal Zone Lymphoma Treatment Market Size by Application
9.3.1 Latin America Marginal Zone Lymphoma Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Marginal Zone Lymphoma Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Marginal Zone Lymphoma Treatment Market Size by Application (2016-2027)
9.4 Latin America Marginal Zone Lymphoma Treatment Market Size by Country
9.4.1 Latin America Marginal Zone Lymphoma Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Marginal Zone Lymphoma Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size (2016-2027)
10.2 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Type
10.2.1 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Application
10.3.1 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Country
10.4.1 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Marginal Zone Lymphoma Treatment Introduction
11.1.4 AbbVie Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Incyte Corporation
11.2.1 Incyte Corporation Company Details
11.2.2 Incyte Corporation Business Overview
11.2.3 Incyte Corporation Marginal Zone Lymphoma Treatment Introduction
11.2.4 Incyte Corporation Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021)
11.2.5 Incyte Corporation Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Marginal Zone Lymphoma Treatment Introduction
11.3.4 Bristol-Myers Squibb Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Marginal Zone Lymphoma Treatment Introduction
11.4.4 Astellas Pharma Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021)
11.4.5 Astellas Pharma Recent Development
11.5 TG Therapeutics
11.5.1 TG Therapeutics Company Details
11.5.2 TG Therapeutics Business Overview
11.5.3 TG Therapeutics Marginal Zone Lymphoma Treatment Introduction
11.5.4 TG Therapeutics Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021)
11.5.5 TG Therapeutics Recent Development
11.6 Genmab AS
11.6.1 Genmab AS Company Details
11.6.2 Genmab AS Business Overview
11.6.3 Genmab AS Marginal Zone Lymphoma Treatment Introduction
11.6.4 Genmab AS Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021)
11.6.5 Genmab AS Recent Development
11.7 Roche
11.7.1 Roche Company Details
11.7.2 Roche Business Overview
11.7.3 Roche Marginal Zone Lymphoma Treatment Introduction
11.7.4 Roche Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021)
11.7.5 Roche Recent Development
11.8 GSK
11.8.1 GSK Company Details
11.8.2 GSK Business Overview
11.8.3 GSK Marginal Zone Lymphoma Treatment Introduction
11.8.4 GSK Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021)
11.8.5 GSK Recent Development
11.9 Johnson & Johnson
11.9.1 Johnson & Johnson Company Details
11.9.2 Johnson & Johnson Business Overview
11.9.3 Johnson & Johnson Marginal Zone Lymphoma Treatment Introduction
11.9.4 Johnson & Johnson Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021)
11.9.5 Johnson & Johnson Recent Development
11.10 Novartis
11.10.1 Novartis Company Details
11.10.2 Novartis Business Overview
11.10.3 Novartis Marginal Zone Lymphoma Treatment Introduction
11.10.4 Novartis Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021)
11.10.5 Novartis Recent Development
11.11 Merck
11.11.1 Merck Company Details
11.11.2 Merck Business Overview
11.11.3 Merck Marginal Zone Lymphoma Treatment Introduction
11.11.4 Merck Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021)
11.11.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Marginal Zone Lymphoma Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Immunotherapy
Table 5. Key Players of Others
Table 6. Global Marginal Zone Lymphoma Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Marginal Zone Lymphoma Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Marginal Zone Lymphoma Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Marginal Zone Lymphoma Treatment Market Share by Regions (2016-2021)
Table 10. Global Marginal Zone Lymphoma Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Marginal Zone Lymphoma Treatment Market Share by Regions (2022-2027)
Table 12. Marginal Zone Lymphoma Treatment Market Trends
Table 13. Marginal Zone Lymphoma Treatment Market Drivers
Table 14. Marginal Zone Lymphoma Treatment Market Challenges
Table 15. Marginal Zone Lymphoma Treatment Market Restraints
Table 16. Global Marginal Zone Lymphoma Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Marginal Zone Lymphoma Treatment Market Share by Players (2016-2021)
Table 18. Global Top Marginal Zone Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Marginal Zone Lymphoma Treatment as of 2020)
Table 19. Ranking of Global Top Marginal Zone Lymphoma Treatment Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Marginal Zone Lymphoma Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Marginal Zone Lymphoma Treatment Product Solution and Service
Table 23. Date of Enter into Marginal Zone Lymphoma Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Marginal Zone Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Marginal Zone Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Table 27. Global Marginal Zone Lymphoma Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Marginal Zone Lymphoma Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Marginal Zone Lymphoma Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Marginal Zone Lymphoma Treatment Revenue Market Share by Application (2016-2021)
Table 31. Global Marginal Zone Lymphoma Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Marginal Zone Lymphoma Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Marginal Zone Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Marginal Zone Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Marginal Zone Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Marginal Zone Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Marginal Zone Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Marginal Zone Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Marginal Zone Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Marginal Zone Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Marginal Zone Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Marginal Zone Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Marginal Zone Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Marginal Zone Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Marginal Zone Lymphoma Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Marginal Zone Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Marginal Zone Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Marginal Zone Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Marginal Zone Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Marginal Zone Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Marginal Zone Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Marginal Zone Lymphoma Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 63. AbbVie Company Details
Table 64. AbbVie Business Overview
Table 65. AbbVie Marginal Zone Lymphoma Treatment Product
Table 66. AbbVie Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 67. AbbVie Recent Development
Table 68. Incyte Corporation Company Details
Table 69. Incyte Corporation Business Overview
Table 70. Incyte Corporation Marginal Zone Lymphoma Treatment Product
Table 71. Incyte Corporation Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 72. Incyte Corporation Recent Development
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Marginal Zone Lymphoma Treatment Product
Table 76. Bristol-Myers Squibb Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Astellas Pharma Company Details
Table 79. Astellas Pharma Business Overview
Table 80. Astellas Pharma Marginal Zone Lymphoma Treatment Product
Table 81. Astellas Pharma Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 82. Astellas Pharma Recent Development
Table 83. TG Therapeutics Company Details
Table 84. TG Therapeutics Business Overview
Table 85. TG Therapeutics Marginal Zone Lymphoma Treatment Product
Table 86. TG Therapeutics Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 87. TG Therapeutics Recent Development
Table 88. Genmab AS Company Details
Table 89. Genmab AS Business Overview
Table 90. Genmab AS Marginal Zone Lymphoma Treatment Product
Table 91. Genmab AS Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 92. Genmab AS Recent Development
Table 93. Roche Company Details
Table 94. Roche Business Overview
Table 95. Roche Marginal Zone Lymphoma Treatment Product
Table 96. Roche Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 97. Roche Recent Development
Table 98. GSK Company Details
Table 99. GSK Business Overview
Table 100. GSK Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 101. GSK Recent Development
Table 102. Johnson & Johnson Company Details
Table 103. Johnson & Johnson Business Overview
Table 104. Johnson & Johnson Marginal Zone Lymphoma Treatment Product
Table 105. Johnson & Johnson Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 106. Johnson & Johnson Recent Development
Table 107. Novartis Company Details
Table 108. Novartis Business Overview
Table 109. Novartis Marginal Zone Lymphoma Treatment Product
Table 110. Novartis Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 111. Novartis Recent Development
Table 112. Merck Company Details
Table 113. Merck Business Overview
Table 114. Merck Marginal Zone Lymphoma Treatment Product
Table 115. Merck Revenue in Marginal Zone Lymphoma Treatment Business (2016-2021) & (US$ Million)
Table 116. Merck Recent Development
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Marginal Zone Lymphoma Treatment Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Immunotherapy Features
Figure 5. Others Features
Figure 6. Global Marginal Zone Lymphoma Treatment Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Marginal Zone Lymphoma Treatment Report Years Considered
Figure 12. Global Marginal Zone Lymphoma Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Marginal Zone Lymphoma Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Marginal Zone Lymphoma Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Marginal Zone Lymphoma Treatment Market Share by Regions (2022-2027)
Figure 16. Global Marginal Zone Lymphoma Treatment Market Share by Players in 2020
Figure 17. Global Top Marginal Zone Lymphoma Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Marginal Zone Lymphoma Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Marginal Zone Lymphoma Treatment Revenue in 2020
Figure 19. Global Marginal Zone Lymphoma Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Marginal Zone Lymphoma Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Marginal Zone Lymphoma Treatment Market Share by Type (2016-2027)
Figure 23. North America Marginal Zone Lymphoma Treatment Market Share by Application (2016-2027)
Figure 24. North America Marginal Zone Lymphoma Treatment Market Share by Country (2016-2027)
Figure 25. United States Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Marginal Zone Lymphoma Treatment Market Share by Type (2016-2027)
Figure 29. Europe Marginal Zone Lymphoma Treatment Market Share by Application (2016-2027)
Figure 30. Europe Marginal Zone Lymphoma Treatment Market Share by Country (2016-2027)
Figure 31. Germany Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Marginal Zone Lymphoma Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Marginal Zone Lymphoma Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Marginal Zone Lymphoma Treatment Market Share by Region (2016-2027)
Figure 41. China Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Marginal Zone Lymphoma Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Marginal Zone Lymphoma Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Marginal Zone Lymphoma Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Marginal Zone Lymphoma Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Marginal Zone Lymphoma Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Marginal Zone Lymphoma Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Marginal Zone Lymphoma Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AbbVie Revenue Growth Rate in Marginal Zone Lymphoma Treatment Business (2016-2021)
Figure 61. Incyte Corporation Revenue Growth Rate in Marginal Zone Lymphoma Treatment Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Marginal Zone Lymphoma Treatment Business (2016-2021)
Figure 63. Astellas Pharma Revenue Growth Rate in Marginal Zone Lymphoma Treatment Business (2016-2021)
Figure 64. TG Therapeutics Revenue Growth Rate in Marginal Zone Lymphoma Treatment Business (2016-2021)
Figure 65. Genmab AS Revenue Growth Rate in Marginal Zone Lymphoma Treatment Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Marginal Zone Lymphoma Treatment Business (2016-2021)
Figure 67. GSK Revenue Growth Rate in Marginal Zone Lymphoma Treatment Business (2016-2021)
Figure 68. Johnson & Johnson Revenue Growth Rate in Marginal Zone Lymphoma Treatment Business (2016-2021)
Figure 69. Novartis Revenue Growth Rate in Marginal Zone Lymphoma Treatment Business (2016-2021)
Figure 70. Merck Revenue Growth Rate in Marginal Zone Lymphoma Treatment Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed

---